CASTIGLIA, Marta
 Distribuzione geografica
Continente #
NA - Nord America 6.354
EU - Europa 2.447
AS - Asia 2.042
SA - Sud America 363
Continente sconosciuto - Info sul continente non disponibili 329
AF - Africa 55
OC - Oceania 6
Totale 11.596
Nazione #
US - Stati Uniti d'America 6.233
SG - Singapore 803
RU - Federazione Russa 678
IT - Italia 619
CN - Cina 523
BR - Brasile 286
DE - Germania 259
FI - Finlandia 205
VN - Vietnam 199
HK - Hong Kong 171
PL - Polonia 124
GB - Regno Unito 123
FR - Francia 110
IE - Irlanda 82
CA - Canada 74
JP - Giappone 64
IN - India 57
SE - Svezia 52
KR - Corea 51
UA - Ucraina 35
BE - Belgio 34
TR - Turchia 31
BD - Bangladesh 28
AR - Argentina 26
NL - Olanda 26
IQ - Iraq 23
RO - Romania 23
ES - Italia 15
EC - Ecuador 14
CI - Costa d'Avorio 13
AT - Austria 12
UZ - Uzbekistan 12
MX - Messico 11
ID - Indonesia 9
IR - Iran 9
JM - Giamaica 9
MY - Malesia 9
VE - Venezuela 9
CH - Svizzera 8
CL - Cile 8
MA - Marocco 8
ZA - Sudafrica 8
DZ - Algeria 7
PH - Filippine 7
PY - Paraguay 7
NP - Nepal 6
PK - Pakistan 6
AU - Australia 5
CO - Colombia 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
DK - Danimarca 5
KE - Kenya 5
LB - Libano 5
LT - Lituania 5
NI - Nicaragua 5
PT - Portogallo 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
HU - Ungheria 4
TN - Tunisia 4
AZ - Azerbaigian 3
EG - Egitto 3
IL - Israele 3
JO - Giordania 3
SA - Arabia Saudita 3
BO - Bolivia 2
DO - Repubblica Dominicana 2
EU - Europa 2
HN - Honduras 2
HR - Croazia 2
KZ - Kazakistan 2
MK - Macedonia 2
PA - Panama 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BY - Bielorussia 1
DM - Dominica 1
EE - Estonia 1
FJ - Figi 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
KG - Kirghizistan 1
KW - Kuwait 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LV - Lettonia 1
Totale 11.260
Città #
Fairfield 847
Ashburn 743
Singapore 535
Woodbridge 377
Chandler 359
San Jose 354
Seattle 346
Wilmington 320
Cambridge 293
Houston 284
Ann Arbor 249
Palermo 164
Hong Kong 160
Moscow 147
Council Bluffs 145
New York 93
Zgierz 93
Helsinki 87
Beijing 82
Los Angeles 81
Dublin 78
Medford 75
The Dalles 73
Des Moines 70
Santa Clara 70
Ho Chi Minh City 65
Boardman 62
Tokyo 60
Nanjing 56
Chicago 51
Altamura 50
Dearborn 50
Lauterbourg 50
Princeton 50
Hanoi 46
San Diego 43
Saint Petersburg 41
Lawrence 38
Dallas 36
Brussels 31
Frankfurt am Main 30
Warsaw 28
Ludwigshafen am Rhein 27
Rome 27
Hefei 26
Phoenix 26
Jinan 24
Shenyang 24
Buffalo 23
Orem 23
Seoul 23
Kitzingen 21
London 21
São Paulo 20
Milan 18
Munich 18
Bremen 17
Montreal 17
Nuremberg 16
Jiaxing 15
Tulsa 15
Tianjin 14
Abidjan 13
Brooklyn 13
Kumar 13
Nanchang 13
Changsha 12
Hebei 12
Redwood City 12
Rio de Janeiro 12
San Paolo di Civitate 11
Stockholm 11
Toronto 11
Columbus 10
Denver 10
Hangzhou 10
Ningbo 10
Surrey 10
Tashkent 10
Baghdad 9
Boston 9
Guangzhou 9
Haiphong 9
Izmir 9
Quito 9
Amsterdam 8
Atlanta 8
Belo Horizonte 8
Boydton 8
Falls Church 8
Jacksonville 8
Naples 8
Zhengzhou 8
Ankara 7
Chennai 7
Da Nang 7
Hanover 7
Mumbai 7
Philadelphia 7
Redondo Beach 7
Totale 7.687
Nome #
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 363
EGFR inhibition in NSCLC: New findings…. and opened questions? 354
Dietary restriction: could it be considered as speed bump on tumor progression road? 331
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines 328
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 321
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE 296
A headlight on liquid biopsies: a challenging tool for breast cancer management 294
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 292
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 287
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects 281
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 278
Spheroids from adipose-derived stem cells exhibit an miRNA profile of highly undifferentiated cells 273
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 273
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 271
Nintedanib in NSCLC: Evidence to date and place in therapy 261
Adipose tissue, angiogenesis and angio-MIR under physiological and pathological conditions 258
Liquid Biopsy in Breast Cancer 256
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 255
Cancer and the microbiome: Potential applications as new tumor biomarker 252
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score 250
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines 247
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS. 243
Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer? 242
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 242
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER 238
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice 235
Immunohistochemical/histochemical double staining method in the study of columnar metaplasia of the oesophagus 223
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes 214
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis 210
Exosomal miRNA analysis in non-small cell lung cancer (NSCLC) patients' plasma through qPCR: A feasible liquid biopsy tool 209
Cell quality evaluation with gene expression analysis of spheroids (3D) and adherent (2D) adipose stem cells 208
Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer 205
Liquid biopsies in lung cancer: The new ambrosia of researchers 203
Improvement in lung cancer outcomes with targeted therapies: An update for family physicians 197
Liquid Biopsy in Non-Small Cell Lung Cancer (NSCLC) 197
An update on the conquests and perspectives of cardio-oncology in the field of tumor angiogenesistargeting TKI-based therapy 192
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines 184
Into the wild of long non-coding RNA in gastrointestinal stromal tumors (GISTs) to explore new prognostic/predictive biomarkers 182
Liquid Biopsy in Gynecological Cancers 177
ALK and crizotinib: After the honeymoon...what else? Resistance mechanisms and new therapies to overcome it 175
Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with Nivolumab 173
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION 170
Technical Aspects for the Evaluation of Circulating Nucleic Acids (CNAs): Circulating Tumor DNA (ctDNA) and Circulating MicroRNAs 162
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 159
Liquid Biopsy in Gastrointestinal Stromal Tumor 151
Corrigendum to "Liquid biopsies in lung cancer: The new ambrosia of researchers" [Biochem. Biophys. Act. 1846(2014) 539-546] 148
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis 143
Molecular analysis of Spheroids from Adipose-derived Stem Cells (S-ASCs) during in vitro long-term culture. 136
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis 114
LIQUID BIOPSY AS A DYNAMIC TOOL FOR LUNG CANCER MANAGEMENT: A FEASIBILITY STUDY FOR PLASMA-DERIVED EXOSOMAL miRNAs AND CELL-FREE DNA. 75
Technical Aspects for the Evaluation of Circulating Tumor Cells (CTCs) 73
Publisher Correction: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis 63
null 25
null 6
P2.06: Exosomal miRNA Analysis in Non-Small Cell Lung Cancer: New Liquid Biomarker?: Track: Biology and Pathogenesis 1
Totale 11.596
Categoria #
all - tutte 37.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.793


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022500 0 0 28 28 30 40 32 38 75 75 49 105
2022/2023981 97 184 19 146 107 142 64 69 94 5 35 19
2023/2024415 16 66 26 33 22 92 46 30 3 12 5 64
2024/20251.111 18 72 61 95 55 39 104 115 53 135 159 205
2025/20263.779 338 130 180 295 417 582 569 379 305 285 130 169
2026/2027469 238 131 100 0 0 0 0 0 0 0 0 0
Totale 11.596